The hidden Australian skin cancer epidemic, high-risk cutaneous squamous cell carcinoma: a narrative review

Andrew Dettrick,Neil Foden,David Hogan,Mary Azer,John Blazak,Daisy Atwell,Nicole Buddle,Myo Min,Ryan Livingston,Leith Banney,Rebecca Donkin
DOI: https://doi.org/10.1016/j.pathol.2024.05.002
IF: 5.335
2024-05-29
Pathology
Abstract:Summary Deaths from non-melanoma skin cancers (NMSCs) have almost doubled in Australia in recent years. Cutaneous squamous cell carcinoma (cSCC) constitutes approximately 20% of NMSCs but is responsible for most of the deaths. Most skin cancers are easy to diagnose and treat and therefore cSCC are often trivialised; however, there is a high-risk subgroup of cSCC (HRcSCC) that is associated with a high risk of metastasis and death. The definition of early HRcSCC and our ability to identify them is still evolving. Many significant prognostic factors have been identified, but a universally accepted prognostic index does not exist. Guidelines for workup, treatment, and follow-up leave many important decisions open to broad interpretation by the treating physician or multidisciplinary team. Some of the treatments used for metastatic cSCC are not supported by robust evidence and the prognosis of metastatic cSCC is guarded. In this review, we highlight the rapid rise in NMSC deaths and discuss some of the deficiencies in our knowledge of how to define, diagnose, stage, and manage HRcSCC.
pathology
What problem does this paper attempt to address?